Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

BC037034 Activators

BC037034 Activators are a diverse array of chemical compounds that indirectly promote the functional activity of BC037034 by modulating cellular signaling pathways. For instance, Forskolin and IBMX both target the cAMP signaling cascade; Forskolin by directly activating adenylate cyclase, and IBMX by inhibiting cAMP degradation. These actions result in elevated cAMP levels, thereby activating PKA, which may phosphorylate BC037034 or associated regulatory proteins, enhancing the activity of BC037034. Sildenafil, by maintaining high levels of cGMP, potentially affects protein kinases that could intersect with BC037034's functional pathways. PMA and Ionomycin exert their effects by activating PKC and increasing intracellular calcium, respectively, both of which could lead to phosphorylation events that enhance BC037034 activity if it is part of these signaling networks. Additionally, EGCG, through the inhibition of various kinases, and LY294002, by impedingPI3K, could alter phosphorylation dynamics, potentially relieving BC037034 from negative regulatory influences or adjusting the signaling equilibrium in favor of BC037034 activation.

Simultaneously, U0126's targeting of the MEK1/2 kinases may indirectly create a favorable signaling environment for BC037034 activity by reducing ERK pathway activity, which could, in turn, affect BC037034's role in signaling. Rapamycin, known for its mTOR inhibitory effect, might lead to an increased BC037034 activity through the activation of alternative signaling routes that compensate when mTOR signaling is suppressed. Thapsigargin and Resveratrol contribute to BC037034 activation through the elevation of cytosolic calcium and the activation of sirtuin pathways, respectively, which can lead to the activation of various calcium-dependent kinases and deacetylation processes that may impact BC037034. Lastly, Staurosporine, despite being a general kinase inhibitor, may selectively facilitate BC037034's functional pathways by removing inhibitory phosphorylations exerted by certain kinases. Together, these BC037034 Activators represent a complex network of chemical interactions that, through their specific mechanisms, converge to enhance the functional activity of BC037034 by targeting different nodes and connections within the cellular signaling architecture.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

IBMX is a non-specific inhibitor of phosphodiesterases, preventing cAMP and cGMP degradation, hence potentiating the cAMP/PKA signaling pathway. This elevated cAMP may indirectly increase BC037034 activity by enhancing PKA-mediated phosphorylation processes.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA is a potent activator of protein kinase C (PKC), which can phosphorylate a wide range of target proteins. Activation of PKC may indirectly lead to the activation of BC037034 if BC037034 is within the PKC signaling cascade.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin is a calcium ionophore that increases intracellular calcium levels, potentially activating calcium-dependent protein kinases such as calmodulin-dependent kinase (CaMK), which may enhance BC037034 activity by phosphorylation.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG is known to inhibit several protein kinases, possibly leading to reduced inhibitory phosphorylation within signaling networks and indirectly enhancing BC037034 activity by alleviating negative regulation.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor that can change downstream signaling pathways, possibly leading to an indirect enhancement of BC037034 activity by altering the balance of signaling through kinases and phosphatases that control BC037034's state.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 is an inhibitor of MEK1/2, which may shift the equilibrium of cellular signaling, potentially favoring pathways that enhance BC037034 activation if BC037034 is regulated by ERK-mediated signaling.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, which may indirectly enhance BC037034 activity by affecting the signaling network that regulates cell growth and survival, potentially leading to activation of compensatory pathways that include BC037034.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium levels which could activate calcium-dependent pathways and indirectly enhance BC037034 activity.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Resveratrol has been shown to activate sirtuin pathways, which may indirectly enhance BC037034 activity through deacetylation of target proteins, potentially including BC037034 or proteins in its regulatory network.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Staurosporine is a broad-spectrum protein kinase inhibitor, which could lead to selective activation of BC037034 pathways by lifting the inhibition exerted by specific kinases on BC037034-related processes.